Quick Answer: Saudi Arabia SFDA cosmetic requirements cover the product itself, its evidence and its market entry. Confirm cosmetic classification; review the formula against current Saudi ingredient lists; establish safety, manufacturing and claim support; prepare compliant Arabic labeling and a retrievable product information file; complete GHAD notification through the appropriate Saudi business; and arrange shipment clearance separately. Notification is not SFDA safety approval.
Last reviewed: 16 October 2026. This guide helps brands, importers and manufacturers plan a Saudi compliance review across the product lifecycle. For portal submission steps, see our Saudi cosmetic registration workflow. Here the focus is what must be ready before that workflow and maintained after launch.
Start with the current Saudi regulatory framework
SFDA regulates cosmetics through the Cosmetics Products Law, its implementing requirements, relevant technical regulations and operational guidance. In its June 2025 update announcement, SFDA identified the adopted 2024 safety and claims regulations and explained that ingredient lists are maintained on the authority’s website. An old formula checklist is therefore insufficient evidence for a new release.
The GSO 1943:2024 official preview establishes the safety, packaging and labeling scope and identifies a Saudi deviation for ingredient lists. Its public preview is not the complete regulation: obtain the applicable full Saudi text and current lists for a clause-by-clause release decision. The Arabic text prevails where the English translation conflicts.
| Framework | Saudi application | Review source |
|---|---|---|
| Gulf safety framework | SFDA adopted SFDA.CO/GSO 1943:2024; assess the Saudi application and deviations | Full applicable Saudi text and current SFDA ingredient lists |
| Gulf claims framework | SFDA adopted SFDA.CO/GSO 2528:2024 for cosmetic claims | Full applicable Saudi claims text |
| Saudi market entry | GHAD notification and separate FASEH consignment procedures | Current SFDA service guidance and importer instructions |
| Area | What to establish | Useful release evidence |
|---|---|---|
| Classification | Intended use, claims and presentation support the cosmetic pathway | Classification rationale and resolved borderline questions |
| Formula and safety | Ingredients and finished product are suitable for the intended use | Reviewed formula, specifications and safety evidence |
| Label and claims | Saudi artwork and marketing match the reviewed product | Approved Arabic artwork and claim support |
| Market entry | Appropriate business, notification and shipment requirements are addressed | GHAD record and consignment plan |
| Lifecycle control | Changes, complaints and traceability have named owners | Controlled revisions and escalation procedure |
Confirm that the product belongs in the cosmetic pathway
Assess the intended purpose, application site, composition and overall presentation together. A moisturizer marketed to improve the appearance of dry skin raises different questions from a product promoted to treat a disease. The name, website, influencer brief and instructions all contribute to the message received by consumers.
Borderline products need an early classification decision before labels are printed or a distributor is promised a launch date. Do not assume that the same formula can carry any claim simply because another market calls it a cosmetic. Document the proposed use and resolve uncertainty through the appropriate SFDA route or qualified local advice.
Review every ingredient against the Saudi lists
The formula owner should provide the complete quantitative composition and material identities, including ingredients supplied within blends. Review prohibited and restricted materials, permitted preservatives, colorants and UV filters using the current Saudi lists and applicable conditions. Record the date, list version or captured reference and the person who performed the assessment.
A material being permitted does not mean every concentration or use is permitted. Restrictions can depend on the product category, application site, population, exposure, required warnings or other conditions. Check the marketed use against those conditions. Assess relevant impurities and material quality as part of the finished product review, rather than treating an INCI name as a complete safety conclusion.
Keep the supplier specification, certificate of analysis and supporting information linked to the actual raw material code. If the factory changes a fragrance, pigment dispersion or preservative blend, require a new review before production. A purchasing substitution can affect the formula, label and compliance file even when the consumer-facing product name stays the same.
Build safety and manufacturing evidence around actual use
Plan the safety assessment and testing around the formulation, intended users, packaging, application area and foreseeable conditions of use. A water-based cream in an open jar poses different microbiological questions from an anhydrous product in a closed pack. The technical reviewer should select justified methods and acceptance criteria rather than ordering an identical generic test bundle for every SKU.
Typical planning topics include microbiological quality, preservation effectiveness where relevant, stability, packaging compatibility and risk-based chemical quality checks. Shelf life and storage instructions should be supported by suitable evidence. Sunscreen or other performance claims need evidence relevant to the finished formula and the exact claim; an ingredient supplier brochure cannot establish the performance of the marketed product.
Ask the manufacturer how good manufacturing practice, batch identification, release specifications and deviations are controlled. Retain an identifiable link between tested samples, formulation revision and production batches. A certificate can support a review, but it does not replace understanding which product and manufacturing site it covers.
| Evidence | Manufacturer contribution | Brand and Saudi business review |
|---|---|---|
| Formula and raw materials | Controlled composition, specifications and supplier information | Confirm intended use and Saudi ingredient review |
| Finished product safety | Test reports, stability and relevant technical support | Verify reports cover the marketed formula and packaging |
| Artwork and claims | Pack dimensions, warnings input and technical claim evidence | Approve Arabic text and all public marketing |
| Traceability | Batch coding, release records and change notifications | Connect stock, complaints and distribution records |
Prepare the product information file before notification
A useful product information file connects identity, composition, manufacturing and safety evidence with the pack actually offered for sale. SFDA’s current notification guidance includes product file responsibilities. Distinguish information entered into the portal from evidence that must remain available: not uploading every report does not remove the need to maintain a compliant product file.
Use a master product record linking the SKU, brand, factory address, formula revision, artwork revision, variants, size and barcode. Maintain accessible supporting records and agree who can retrieve them when requested. Confidential factory information needs a controlled sharing arrangement; a verbal promise to supply documents later is a weak launch dependency.
For an OEM or ODM cosmetics project, define the document handover in the manufacturing agreement. Specify the technical contact, change-notification process and responsibilities for answering authority questions. The brand remains involved in claims and product identity even when the factory compiles much of the technical evidence.
Review Arabic labeling and every product claim
Prepare Saudi artwork against the applicable full labeling rules, including required language, identity, ingredient declaration, quantity, traceability, dates or durability information, precautions and responsible business details as applicable. Review the container, carton and any leaflet as a set. Do not treat this planning list as a substitute for category-specific label requirements.
Have a competent Arabic reviewer assess the complete joined sentences on the actual dieline. Direction, punctuation, units, ingredient exceptions and warning placement need visual checking at final print size. Verify that over-labels remain legible and durable and do not conceal required information. A translation approved in a spreadsheet can still fail when fitted into a narrow bottle label.
The GSO 2528:2024 official preview identifies the separate technical regulation for cosmetic claims. Obtain the full applicable rules and assess express and implied claims across packaging, product pages and advertising. Avoid disease-treatment language, unsupported numerical results and messages that imply notification is government endorsement.
Keep GHAD notification separate from consignment clearance
Current SFDA guidance describes GHAD as the unified electronic system for cosmetic notification; eCosma appears in older instructions. Identify the appropriate Saudi notifying business and applicable account or licensing requirements, then submit consistent product and manufacturer information. Retain the final record and reference against the reviewed SKU.
Product notification does not certify that SFDA tested the product or relieve the notifier of compliance responsibility. Shipment entry is another workstream. SFDA’s FASEH service explanation describes the consignment process following the relevant product and business preparation. Ask the importer and conformity partners to confirm current shipment-specific requirements before freight is booked.
| Gate | Decision to record | Stop if |
|---|---|---|
| Before artwork purchase | Classification, formula and claims are reviewed | A material restriction or borderline claim remains unresolved |
| Before production release | Pack and technical file match the approved revision | Supplier changes have not been assessed |
| Before shipment | Notification and consignment arrangements are confirmed | SKU, size or manufacturing identity differs |
| After launch | Complaints and changes enter a controlled review | Safety signals or nonconforming stock lack an owner |
Maintain compliance after the first sale
Assign ownership for complaints, undesirable effects, investigations, corrective actions and withdrawals. Maintain batch and distribution records that allow affected stock to be identified. Ensure the brand, factory and importer know who receives a safety concern and who makes the next decision; an unanswered shared inbox is not a workable escalation process.
Assess formula, manufacturing site, pack, name, claims and other material changes before revised stock is released. Determine the required notification or file updates through current instructions. Review regulatory changes periodically and retain the assessment. Use our global cosmetics registration guide to coordinate multiple markets, while keeping a specific Saudi decision record.
For a new range, contact our team with the product type and target market to plan manufacturer documentation and production handover. Start with the exact formula and intended claims so the technical work supports the product you plan to sell.
Frequently asked questions
Does SFDA notification prove that a cosmetic is safe?
No. Notification records the product through the applicable process. The responsible businesses must establish and maintain compliance and supporting safety evidence.
Can an EU-compliant formula be sold unchanged in Saudi Arabia?
Do not assume so. Review the current Saudi ingredient lists, labeling, claims, product file and market-entry requirements against the actual product.
Is GHAD the same as eCosma?
Current SFDA guidance uses GHAD. Verify current instructions and existing records rather than relying on historic eCosma tutorials.
Who supplies the technical evidence for private label cosmetics?
The manufacturer supplies essential formula, manufacturing and testing information. Agree the handover with the brand and Saudi business, including access, updates and authority queries.
Does every cosmetic need the same testing package?
No universal package should be assumed. A qualified technical review should determine suitable evidence from the formula, exposure, packaging, claims and applicable requirements.
Disclaimer: This is general planning information, not legal advice or an SFDA approval. Check current official requirements and obtain product-specific regulatory advice before manufacture, import or sale.